First Sub-unit Tuberculosis Vaccine Shows Promise to Protect
The results from an innovative clinical trial provide new evidence that Tuberculosis (TB) vaccines could prevent sustained infections in high-risk adolescents. The trial has been conducted by Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer